human pancreatic stem cells Search Results


human pancreatic cancer stem cells cscs  (Celprogen Inc)
92
Celprogen Inc human pancreatic cancer stem cells cscs
The expression of EN2 in HPNE, <t>pancreatic</t> cancer cell lines, and pancreatic <t>CSCs.</t> (A), Protein expression of EN2 in HPNE, pancreatic cancer cell lines, and pancreatic CSCs. Crude proteins were isolated, and EN2 expression was measured by Western blot analysis. β‐Actin was used as a loading control. (B), Expression of EN2 mRNA in HPNE, pancreatic cancer cell lines, and pancreatic CSCs. RNA was isolated, and EN2 expression was measured by q‐RT‐PCR. GAPDH was used as an internal control. Data represent mean ( n = 4) ± SD. *, # and % = significantly different from HPNE ( p < 0.05). (C), Expression of EN2. Immunocytochemistry was performed to examine EN2 expression in HPNE, PANC‐1, and AsPC‐1 cells.
Human Pancreatic Cancer Stem Cells Cscs, supplied by Celprogen Inc, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/human+pancreatic+stem+cells/Human+Pancreatic+Cancer+Stem+Cells/pmc13111425-43-0-9
Average 92 stars, based on 1 article reviews
human pancreatic cancer stem cells cscs - by Bioz Stars, 2026-10
92/100 stars
  Buy from Supplier
pancreatic cancer stem cell extracellular matrix  (Celprogen Inc)
90
Celprogen Inc pancreatic cancer stem cell extracellular matrix
The expression of EN2 in HPNE, <t>pancreatic</t> cancer cell lines, and pancreatic <t>CSCs.</t> (A), Protein expression of EN2 in HPNE, pancreatic cancer cell lines, and pancreatic CSCs. Crude proteins were isolated, and EN2 expression was measured by Western blot analysis. β‐Actin was used as a loading control. (B), Expression of EN2 mRNA in HPNE, pancreatic cancer cell lines, and pancreatic CSCs. RNA was isolated, and EN2 expression was measured by q‐RT‐PCR. GAPDH was used as an internal control. Data represent mean ( n = 4) ± SD. *, # and % = significantly different from HPNE ( p < 0.05). (C), Expression of EN2. Immunocytochemistry was performed to examine EN2 expression in HPNE, PANC‐1, and AsPC‐1 cells.
Pancreatic Cancer Stem Cell Extracellular Matrix, supplied by Celprogen Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/human+pancreatic+stem+cells/Human+Pancreatic+Cancer+Stem+Cell+Extracellular+Matrix/pmc05818288-111-3-12
Average 90 stars, based on 1 article reviews
pancreatic cancer stem cell extracellular matrix - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier
pancreatic cancer stem cell complete growth media  (Celprogen Inc)
90
Celprogen Inc pancreatic cancer stem cell complete growth media
Fig. 5. Cellular uptake studies in monolayer and microtumor cultures of prostate and <t>pancreatic</t> cancer stem cells. Panels (A–F): prostate cancer stem cells (scale bar: 25 m), and
Pancreatic Cancer Stem Cell Complete Growth Media, supplied by Celprogen Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/human+pancreatic+stem+cells/Human+Pancreatic+Cancer+Stem+Cell+Complete+Media+with+Serum/pm29304437-104-28-40
Average 90 stars, based on 1 article reviews
pancreatic cancer stem cell complete growth media - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier
xenograft pancreatic cancer stem cells cscs  (Celprogen Inc)
92
Celprogen Inc xenograft pancreatic cancer stem cells cscs
Fig. 6 Interaction of the block copolymers and HDAC8-responsive nanoparticles with different types of PDAC cells and non-cancerous HPNE cells in vitro. (A) PEG-block-poly(acetylated L-lysine) block copolymers studied in this work do not trigger cytotoxicity in different cell lines. (B) Chemical structure of the STAT3 inhibitor, Napabucasin (NAPA), which has been used as the model hydrophobic drug to demonstrate the encapsulation and HDAC-mediated release activity of the nanoparticles in the context of drug delivery. (C) HDAC 8 (1 mM) triggers the release of NAPA, and over 90% of the encapsulated drug is released from these nanoparticles after incubation with the enzyme for 3 h. The standard deviation of mean is taken for N = 3 replicates. Without the enzyme, the drug release rate and extent were significantly decreased. (D) NAPA-loaded nanoparticles showed a concentration- dependent effect on different types of cancer cells, with a more prominent effect on cancer stem cells <t>(CSCs).</t>
Xenograft Pancreatic Cancer Stem Cells Cscs, supplied by Celprogen Inc, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/human+pancreatic+stem+cells/Human+Pancreatic+Cancer+Stem+Cell+Patient-Derived+Xenografts/pm39021201-168-6-14
Average 92 stars, based on 1 article reviews
xenograft pancreatic cancer stem cells cscs - by Bioz Stars, 2026-10
92/100 stars
  Buy from Supplier
human embryonic stem cell-derived pancreatic progenitor cells  (Balzer GmbH)
90
Balzer GmbH human embryonic stem cell-derived pancreatic progenitor cells
Fig. 6 Interaction of the block copolymers and HDAC8-responsive nanoparticles with different types of PDAC cells and non-cancerous HPNE cells in vitro. (A) PEG-block-poly(acetylated L-lysine) block copolymers studied in this work do not trigger cytotoxicity in different cell lines. (B) Chemical structure of the STAT3 inhibitor, Napabucasin (NAPA), which has been used as the model hydrophobic drug to demonstrate the encapsulation and HDAC-mediated release activity of the nanoparticles in the context of drug delivery. (C) HDAC 8 (1 mM) triggers the release of NAPA, and over 90% of the encapsulated drug is released from these nanoparticles after incubation with the enzyme for 3 h. The standard deviation of mean is taken for N = 3 replicates. Without the enzyme, the drug release rate and extent were significantly decreased. (D) NAPA-loaded nanoparticles showed a concentration- dependent effect on different types of cancer cells, with a more prominent effect on cancer stem cells <t>(CSCs).</t>
Human Embryonic Stem Cell Derived Pancreatic Progenitor Cells, supplied by Balzer GmbH, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/human+pancreatic+stem+cells/human+embryonic+stem+cell+derived+pancreatic+progenitor+cells/10__1530_slash_joe___23___0308-278-42-23
Average 90 stars, based on 1 article reviews
human embryonic stem cell-derived pancreatic progenitor cells - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier
human pancreatic stem cells  (Celprogen Inc)
89
Celprogen Inc human pancreatic stem cells
Fig. 6 Interaction of the block copolymers and HDAC8-responsive nanoparticles with different types of PDAC cells and non-cancerous HPNE cells in vitro. (A) PEG-block-poly(acetylated L-lysine) block copolymers studied in this work do not trigger cytotoxicity in different cell lines. (B) Chemical structure of the STAT3 inhibitor, Napabucasin (NAPA), which has been used as the model hydrophobic drug to demonstrate the encapsulation and HDAC-mediated release activity of the nanoparticles in the context of drug delivery. (C) HDAC 8 (1 mM) triggers the release of NAPA, and over 90% of the encapsulated drug is released from these nanoparticles after incubation with the enzyme for 3 h. The standard deviation of mean is taken for N = 3 replicates. Without the enzyme, the drug release rate and extent were significantly decreased. (D) NAPA-loaded nanoparticles showed a concentration- dependent effect on different types of cancer cells, with a more prominent effect on cancer stem cells <t>(CSCs).</t>
Human Pancreatic Stem Cells, supplied by Celprogen Inc, used in various techniques. Bioz Stars score: 89/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/human+pancreatic+stem+cells/Human+Pancreatic+Stem+Cells/custom%40360040-05-t150%4031478752
Average 89 stars, based on 1 article reviews
human pancreatic stem cells - by Bioz Stars, 2026-10
89/100 stars
  Buy from Supplier
pluripotent stem cell-derived human pancreatic ductal epithelial cells  (StemCells Inc)
90
StemCells Inc pluripotent stem cell-derived human pancreatic ductal epithelial cells
Fig. 6 Interaction of the block copolymers and HDAC8-responsive nanoparticles with different types of PDAC cells and non-cancerous HPNE cells in vitro. (A) PEG-block-poly(acetylated L-lysine) block copolymers studied in this work do not trigger cytotoxicity in different cell lines. (B) Chemical structure of the STAT3 inhibitor, Napabucasin (NAPA), which has been used as the model hydrophobic drug to demonstrate the encapsulation and HDAC-mediated release activity of the nanoparticles in the context of drug delivery. (C) HDAC 8 (1 mM) triggers the release of NAPA, and over 90% of the encapsulated drug is released from these nanoparticles after incubation with the enzyme for 3 h. The standard deviation of mean is taken for N = 3 replicates. Without the enzyme, the drug release rate and extent were significantly decreased. (D) NAPA-loaded nanoparticles showed a concentration- dependent effect on different types of cancer cells, with a more prominent effect on cancer stem cells <t>(CSCs).</t>
Pluripotent Stem Cell Derived Human Pancreatic Ductal Epithelial Cells, supplied by StemCells Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/human+pancreatic+stem+cells/pluripotent+stem+cell+derived+human+pancreatic+ductal+epithelial+cells/pm37708421-644-8-11
Average 90 stars, based on 1 article reviews
pluripotent stem cell-derived human pancreatic ductal epithelial cells - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier
highqc pancreatic beta cells derived from human induced pluripotent stem cell  (AcceGen Biotechnology)
N/A
Pancreatic Beta Cells have been differentiated from our human induced pluripotent stem (hiPS) cells, dissociated into a single-cell suspension, and frozen in vials.
   Buy from Supplier
human pancreatic transdifferentiated from human stem cell freezing media  (Celprogen Inc)
N/A
Human Pancreatic transdifferentiated from Human Stem Cell Freezing Media Optimized for freezing Human Pancreatic transdifferentiated from Human Stem Cells Cat# 36004-05. This product is tissue culture tested and is available as 100ml sterile filtered unit.
   Buy from Supplier
human normal pancreatic progenitor stem cell culture  (Celprogen Inc)
N/A
Human Normal Pancreatic Progenitor Stem Cell Culture - Frozen Vial Also Avaliable as: T25 plated cells shipped at room temperature. Cat#36169-14N-T25 T75 plated cells shipped at room temperature. Cat#36169-14N-T75 T150 Plated Cells shipped at room
   Buy from Supplier
human pancreatic stem cell expansion media with serum  (Celprogen Inc)
N/A
Human Pancreatic Stem Cell Expansion Media with Serum. This product is also available without Serum Cat# M36097-24E This product would require pre-coated flasks with Human Pancreatic Stem Cell Extra-cellular Expansion Matrix Cat# E36097-24 and Human
   Buy from Supplier
human pancreatic cancer stem cell culture serum free un-differentiation media  (Celprogen Inc)
N/A
Human Pancreatic Cancer Stem Cell Culture Serum Free Undifferentiation Media. This product is also available with Serum Cat# M36115-45US This product would require pre-coated flasks with Human Pancreatic Cancer Stem Cell Culture Extra-cellular Un-differentiation Matrix
   Buy from Supplier

Image Search Results


The expression of EN2 in HPNE, pancreatic cancer cell lines, and pancreatic CSCs. (A), Protein expression of EN2 in HPNE, pancreatic cancer cell lines, and pancreatic CSCs. Crude proteins were isolated, and EN2 expression was measured by Western blot analysis. β‐Actin was used as a loading control. (B), Expression of EN2 mRNA in HPNE, pancreatic cancer cell lines, and pancreatic CSCs. RNA was isolated, and EN2 expression was measured by q‐RT‐PCR. GAPDH was used as an internal control. Data represent mean ( n = 4) ± SD. *, # and % = significantly different from HPNE ( p < 0.05). (C), Expression of EN2. Immunocytochemistry was performed to examine EN2 expression in HPNE, PANC‐1, and AsPC‐1 cells.

Journal: Journal of Cellular and Molecular Medicine

Article Title: EN2 Regulates Pancreatic Cancer Initiation, Progression, and Epithelial‐Mesenchymal Transition Through the Notch Signalling Pathway

doi: 10.1111/jcmm.71158

Figure Lengend Snippet: The expression of EN2 in HPNE, pancreatic cancer cell lines, and pancreatic CSCs. (A), Protein expression of EN2 in HPNE, pancreatic cancer cell lines, and pancreatic CSCs. Crude proteins were isolated, and EN2 expression was measured by Western blot analysis. β‐Actin was used as a loading control. (B), Expression of EN2 mRNA in HPNE, pancreatic cancer cell lines, and pancreatic CSCs. RNA was isolated, and EN2 expression was measured by q‐RT‐PCR. GAPDH was used as an internal control. Data represent mean ( n = 4) ± SD. *, # and % = significantly different from HPNE ( p < 0.05). (C), Expression of EN2. Immunocytochemistry was performed to examine EN2 expression in HPNE, PANC‐1, and AsPC‐1 cells.

Article Snippet: Human pancreatic cancer stem cells (CSCs) were obtained from Celprogen and cultured in a well‐defined medium according to the manufacturer's instructions.

Techniques: Expressing, Isolation, Western Blot, Control, Reverse Transcription Polymerase Chain Reaction, Immunocytochemistry

Fig. 5. Cellular uptake studies in monolayer and microtumor cultures of prostate and pancreatic cancer stem cells. Panels (A–F): prostate cancer stem cells (scale bar: 25 m), and

Journal: Colloids and surfaces. B, Biointerfaces

Article Title: Peptide-targeted, stimuli-responsive polymersomes for delivering a cancer stemness inhibitor to cancer stem cell microtumors.

doi: 10.1016/j.colsurfb.2017.12.036

Figure Lengend Snippet: Fig. 5. Cellular uptake studies in monolayer and microtumor cultures of prostate and pancreatic cancer stem cells. Panels (A–F): prostate cancer stem cells (scale bar: 25 m), and

Article Snippet: Prostate cancer stem cells were maintained in human prostate cancer stem cell complete growth media with serum and antibiotics and pancreatic cancer stem cell were maintained in human pancreatic cancer stem cell complete growth media with serum and antibiotics from Celprogen.

Techniques:

Fig. 6. Expression of neuropilin-1 in prostate and pancreatic cancer stem cells as determined

Journal: Colloids and surfaces. B, Biointerfaces

Article Title: Peptide-targeted, stimuli-responsive polymersomes for delivering a cancer stemness inhibitor to cancer stem cell microtumors.

doi: 10.1016/j.colsurfb.2017.12.036

Figure Lengend Snippet: Fig. 6. Expression of neuropilin-1 in prostate and pancreatic cancer stem cells as determined

Article Snippet: Prostate cancer stem cells were maintained in human prostate cancer stem cell complete growth media with serum and antibiotics and pancreatic cancer stem cell were maintained in human pancreatic cancer stem cell complete growth media with serum and antibiotics from Celprogen.

Techniques: Expressing

Fig. 7. The viability of prostate and pancreatic cancer stem cells in monolayer and spheroid cultures. (A) Monolayer cultures of prostate cancer stem cells, (B) monolayer cultures

Journal: Colloids and surfaces. B, Biointerfaces

Article Title: Peptide-targeted, stimuli-responsive polymersomes for delivering a cancer stemness inhibitor to cancer stem cell microtumors.

doi: 10.1016/j.colsurfb.2017.12.036

Figure Lengend Snippet: Fig. 7. The viability of prostate and pancreatic cancer stem cells in monolayer and spheroid cultures. (A) Monolayer cultures of prostate cancer stem cells, (B) monolayer cultures

Article Snippet: Prostate cancer stem cells were maintained in human prostate cancer stem cell complete growth media with serum and antibiotics and pancreatic cancer stem cell were maintained in human pancreatic cancer stem cell complete growth media with serum and antibiotics from Celprogen.

Techniques:

Fig. 9. Flow cytometry analysis of the effect of napabucasin on prostate (A) and pancreatic cancer stem cells (B) with Annexin V and PI staining.

Journal: Colloids and surfaces. B, Biointerfaces

Article Title: Peptide-targeted, stimuli-responsive polymersomes for delivering a cancer stemness inhibitor to cancer stem cell microtumors.

doi: 10.1016/j.colsurfb.2017.12.036

Figure Lengend Snippet: Fig. 9. Flow cytometry analysis of the effect of napabucasin on prostate (A) and pancreatic cancer stem cells (B) with Annexin V and PI staining.

Article Snippet: Prostate cancer stem cells were maintained in human prostate cancer stem cell complete growth media with serum and antibiotics and pancreatic cancer stem cell were maintained in human pancreatic cancer stem cell complete growth media with serum and antibiotics from Celprogen.

Techniques: Flow Cytometry, Staining

Fig. 6 Interaction of the block copolymers and HDAC8-responsive nanoparticles with different types of PDAC cells and non-cancerous HPNE cells in vitro. (A) PEG-block-poly(acetylated L-lysine) block copolymers studied in this work do not trigger cytotoxicity in different cell lines. (B) Chemical structure of the STAT3 inhibitor, Napabucasin (NAPA), which has been used as the model hydrophobic drug to demonstrate the encapsulation and HDAC-mediated release activity of the nanoparticles in the context of drug delivery. (C) HDAC 8 (1 mM) triggers the release of NAPA, and over 90% of the encapsulated drug is released from these nanoparticles after incubation with the enzyme for 3 h. The standard deviation of mean is taken for N = 3 replicates. Without the enzyme, the drug release rate and extent were significantly decreased. (D) NAPA-loaded nanoparticles showed a concentration- dependent effect on different types of cancer cells, with a more prominent effect on cancer stem cells (CSCs).

Journal: Journal of materials chemistry. B

Article Title: Design and evaluation of nanoscale materials with programmed responsivity towards epigenetic enzymes.

doi: 10.1039/d4tb00514g

Figure Lengend Snippet: Fig. 6 Interaction of the block copolymers and HDAC8-responsive nanoparticles with different types of PDAC cells and non-cancerous HPNE cells in vitro. (A) PEG-block-poly(acetylated L-lysine) block copolymers studied in this work do not trigger cytotoxicity in different cell lines. (B) Chemical structure of the STAT3 inhibitor, Napabucasin (NAPA), which has been used as the model hydrophobic drug to demonstrate the encapsulation and HDAC-mediated release activity of the nanoparticles in the context of drug delivery. (C) HDAC 8 (1 mM) triggers the release of NAPA, and over 90% of the encapsulated drug is released from these nanoparticles after incubation with the enzyme for 3 h. The standard deviation of mean is taken for N = 3 replicates. Without the enzyme, the drug release rate and extent were significantly decreased. (D) NAPA-loaded nanoparticles showed a concentration- dependent effect on different types of cancer cells, with a more prominent effect on cancer stem cells (CSCs).

Article Snippet: The fourth cell variant is patient-derived xenograft pancreatic cancer stem cells (CSCs) obtained from Celprogen.

Techniques: Blocking Assay, In Vitro, Encapsulation, Activity Assay, Incubation, Standard Deviation, Concentration Assay